1. Home
  2. NVAX vs CUBI Comparison

NVAX vs CUBI Comparison

Compare NVAX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.19

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$79.31

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
CUBI
Founded
1987
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
NVAX
CUBI
Price
$9.19
$79.31
Analyst Decision
Hold
Buy
Analyst Count
9
8
Target Price
$11.33
$85.00
AVG Volume (30 Days)
5.4M
197.2K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
309.76
22.99
EPS
N/A
4.02
Revenue
$1,123,479,000.00
N/A
Revenue This Year
N/A
$24.95
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
$19.62
Revenue Growth
64.69
N/A
52 Week Low
$6.20
$59.34
52 Week High
$11.85
$84.38

Technical Indicators

Market Signals
Indicator
NVAX
CUBI
Relative Strength Index (RSI) 54.54 47.37
Support Level $9.14 $74.77
Resistance Level $10.10 $79.59
Average True Range (ATR) 0.58 1.68
MACD -0.04 -0.06
Stochastic Oscillator 29.04 52.02

Price Performance

Historical Comparison
NVAX
CUBI

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

Share on Social Networks: